Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia Trial.

NCT01702636 is registered in ClinicalTrials.gov with Neuroscience Trials Australia as lead sponsor.

NCT NCT01702636
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01702636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia Trial.
Lead sponsor
Neuroscience Trials Australia
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2012
Completion date
December 31, 2019
Enrollment
100 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

intracerebral haemorrhage, stroke